Document Detail

"7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial".
MedLine Citation:
PMID:  22103045     Owner:  NLM     Status:  MEDLINE    
BACKGROUND & STUDY AIMS: Increasing data suggests that the efficiency of standard triple therapies of 7-10-14 days duration has fallen below the threshold for acceptability (80% cure rates in intention to treat analysis). Use of rabeprazole, a PPI less influenced by CYP2C19 gene polymorphisms is reported to lead to improved eradication rates. This study aims to re-examine the effectiveness of 7-10-14 days triple therapies based on rabeprazole in Greek patients.
PATIENTS AND METHODS: 307 patients, from 2 endoscopic centers in Greece, were randomized to receive Rabeprazole 20 mg bid, Clarithromycin 500 mg bid, and Amoxycillin 1gr bid for 7-days, for 10-days or for 14-days. Cure rates were assessed by CLO-test and histology. Clarithromycin sensitivity tests were carried out in the cultured pre-treatment H.pylori strains. The success rates were calculated by both intention-to-treat (ITT) and per protocol (PP) analyses.
RESULTS: The eradication rates according to ITT analyses were 74.5% (95% CI: 66.5-82.9%) for 7-days, 80.6% (95% CI: 73.2-88.2%) for 10-days and 90.2% (95% CI: 84.5-95.9%) for 14-days treatment. PP cure rates were 76% (95% CI: 68.4-85.0%) for 7-days, 83% (95% CI: 76.6-91.0%) for 10-days and 93.9% (95% CI: 86.7-973%) for 14-days treatment. Side effects were generally minor and comparable in all treatment groups.
CONCLUSIONS: Both 10- and 14-days rabeprazole-based triple regimens reached eradication rates above the threshold of 80% on an intention to treat basis. In our setting, the current regimen using rabeprazole, amoxicillin and clarithromycin was well tolerated, is still effective and should continue to be recommended as first-line therapy for H. pylori eradication.
S Karatapanis; S D Georgopoulos; V Papastergiou; L Skorda; N Papantoniou; Ph Lisgos; C Kouvidou; P Fragkou; A Mentis
Related Documents :
7800005 - Antibacterial treatment of gastric ulcers associated with helicobacter pylori.
25328865 - Circulating tumor cells in patients with metastatic castration resistant prostate cance...
21980715 - Refractory hailey-hailey disease successfully treated with sandpaper dermabrasion.
25163495 - Levofloxacin-containing second-line anti-helicobacter pylori eradication in taiwanese r...
3839805 - Radiotherapy of severe ophthalmic graves' disease.
45725 - Improvement of pancreatic cancer model by modified treatment with n-nitroso-bis (2-oxop...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Acta gastro-enterologica Belgica     Volume:  74     ISSN:  0001-5644     ISO Abbreviation:  Acta Gastroenterol. Belg.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-11-22     Completed Date:  2011-12-20     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  0414075     Medline TA:  Acta Gastroenterol Belg     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  407-12     Citation Subset:  IM    
First Department of Internal Medicine, General Hospital of Rhodes, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
2-Pyridinylmethylsulfinylbenzimidazoles / administration & dosage*
Amoxicillin / administration & dosage
Anti-Bacterial Agents / administration & dosage*
Anti-Ulcer Agents / administration & dosage*
Clarithromycin / administration & dosage
Drug Therapy, Combination
Helicobacter Infections / drug therapy*
Helicobacter pylori / drug effects*
Middle Aged
Young Adult
Reg. No./Substance:
0/2-Pyridinylmethylsulfinylbenzimidazoles; 0/Anti-Bacterial Agents; 0/Anti-Ulcer Agents; 26787-78-0/Amoxicillin; 32828355LL/rabeprazole; 81103-11-9/Clarithromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single-centre experience on use of videocapsule endoscopy for obscure gastrointestinal bleeding in 1...
Next Document:  Familial adenomatous polyposis: clinical presentation, detection and surveillance.